Home> Products> non scarring hair loss

{ "products": [ { "_id": "6a2946ad843464e913198338", "fptag": "STERISHEALTHCARE", "merchantname": null, "customwidgets": null, "externalsourceid": null, "name": "Minoxidil & Finasteride Topical Solution", "description": "Introduction\n\nMinoxidil & Finasteride Topical Solution is an advanced hair restoration treatment designed to combat hair loss and promote healthy hair regrowth in individuals suffering from androgenetic alopecia (male and female pattern hair loss). This powerful combination brings together two scientifically proven ingredients—Minoxidil and Finasteride—that work through different mechanisms to address the root causes of hair thinning and hair fall.\n\nHair loss affects millions of people worldwide and can significantly impact self-confidence, appearance, and emotional well-being. While hair loss may occur due to genetics, hormonal changes, aging, stress, or lifestyle factors, androgenetic alopecia remains the most common cause. Minoxidil & Finasteride Topical Solution provides a targeted approach by stimulating hair follicles and reducing the hormonal effects responsible for follicle shrinkage.\n\nThis comprehensive guide covers everything you need to know about Minoxidil & Finasteride Topical Solution, including its composition, mechanism of action, uses, benefits, side effects, precautions, and frequently asked questions.\n\nWhat Is Minoxidil & Finasteride Topical Solution?\n\nMinoxidil & Finasteride Topical Solution is a topical hair growth treatment applied directly to the scalp. It combines two active ingredients known for their effectiveness in treating pattern baldness and progressive hair thinning.\n\nThe solution is formulated to:\n\nReduce hair fall\nStimulate dormant hair follicles\nPromote new hair growth\nIncrease hair density\nImprove scalp coverage\nSlow down hair loss progression\n\nUnlike oral therapies, topical application delivers the active ingredients directly to the affected area, helping improve local effectiveness while minimizing systemic exposure.\n\nComposition of Minoxidil & Finasteride Topical Solution\nActive Ingredients\nMinoxidil\n\nMinoxidil is a vasodilator that helps improve blood circulation around hair follicles and encourages hair growth.\n\nFinasteride\n\nFinasteride is a 5-alpha reductase inhibitor that reduces the production of dihydrotestosterone (DHT), a hormone strongly linked to pattern hair loss.\n\nThe combination of these two ingredients provides a comprehensive solution for managing hair thinning and hair loss.\n\nHow Does Minoxidil & Finasteride Topical Solution Work?\n\nThe effectiveness of this solution lies in the complementary actions of Minoxidil and Finasteride.\n\nHow Minoxidil Works\n\nMinoxidil helps stimulate hair growth by:\n\nIncreasing Blood Flow\n\nIt widens blood vessels in the scalp, improving oxygen and nutrient delivery to hair follicles.\n\nActivating Dormant Follicles\n\nMinoxidil helps revive weakened follicles that have stopped producing healthy hair.\n\nExtending the Growth Phase\n\nThe medication prolongs the anagen (growth) phase of the hair cycle.\n\nImproving Hair Thickness\n\nRegular use promotes stronger and thicker hair strands.\n\nHow Finasteride Works\n\nFinasteride addresses one of the primary causes of hereditary hair loss.\n\nReduces DHT Production\n\nDHT (Dihydrotestosterone) is a hormone responsible for shrinking hair follicles in genetically susceptible individuals.\n\nPrevents Follicular Miniaturization\n\nBy lowering DHT levels in the scalp, Finasteride helps maintain follicle size and function.\n\nSlows Hair Loss Progression\n\nFinasteride helps preserve existing hair and reduces ongoing thinning.\n\nCombined Action\n\nTogether, Minoxidil and Finasteride:\n\nPromote active hair growth\nProtect existing hair follicles\nReduce hair shedding\nImprove hair density\nEncourage healthier scalp conditions\nDeliver long-term hair restoration support\nUses of Minoxidil & Finasteride Topical Solution\n1. Treatment of Androgenetic Alopecia\n\nThe primary use of Minoxidil & Finasteride Topical Solution is the management of hereditary hair loss.\n\nThis includes:\n\nMale pattern baldness\nFemale pattern hair thinning\nCrown hair loss\nReceding hairline\nDiffuse thinning\n2. Hair Regrowth Therapy\n\nThe solution stimulates weakened follicles and encourages new hair production in affected scalp areas.\n\n3. Reduction of Excessive Hair Fall\n\nRegular application can help reduce daily hair shedding and improve hair retention.\n\n4. Improvement of Hair Density\n\nThe treatment promotes fuller-looking hair by increasing follicular activity.\n\n5. Maintenance of Existing Hair\n\nFinasteride helps preserve healthy follicles and prevent further hair loss progression.\n\nKey Benefits of Minoxidil & Finasteride Topical Solution\nDual Mechanism for Hair Growth\n\nUnlike single-ingredient products, this solution targets hair loss through two scientifically proven pathways.\n\nBenefits include:\nEnhanced effectiveness\nBetter hair retention\nImproved follicle health\nClinically Proven Ingredients\n\nBoth Minoxidil and Finasteride have been extensively studied and widely recommended by dermatologists and hair restoration specialists.\n\nStimulates New Hair Growth\n\nThe solution helps activate dormant follicles and support the production of healthier hair strands.\n\nReduces Hair Thinning\n\nConsistent use may significantly reduce visible scalp exposure caused by thinning hair.\n\nImproves Hair Thickness\n\nUsers often experience:\n\nStronger hair shafts\nIncreased volume\nFuller appearance\nSlows Pattern Baldness\n\nFinasteride helps address the hormonal component of hair loss, making it particularly effective for androgenetic alopecia.\n\nEasy Topical Application\n\nThe solution can be applied directly to affected areas using a dropper or spray applicator.\n\nSupports Long-Term Hair Health\n\nWith ongoing use, the treatment can contribute to sustained follicular activity and improved scalp coverage.\n\nWhy Choose Minoxidil & Finasteride Topical Solution?\nComprehensive Hair Loss Management\n\nThe combination addresses both:\n\nHair follicle stimulation\nHormonal hair loss triggers\n\nThis makes it more effective than many single-agent treatments.\n\nNon-Surgical Alternative\n\nThe solution offers a convenient and non-invasive option for individuals seeking hair restoration without surgery.\n\nConvenient Daily Use\n\nEasy application allows incorporation into daily grooming routines.\n\nCost-Effective Treatment\n\nCompared with hair transplant procedures, topical therapy is often more affordable and accessible.\n\nTrusted by Hair Specialists\n\nMany dermatologists recommend Minoxidil and Finasteride combinations for suitable patients experiencing pattern hair loss.\n\nWho Can Benefit from Minoxidil & Finasteride Topical Solution?\n\nThis treatment may be suitable for:\n\nAdults with male pattern baldness\nIndividuals with hereditary hair loss\nPatients experiencing progressive hair thinning\nPeople seeking non-surgical hair restoration\nThose with early to moderate stages of alopecia\n\nA healthcare professional should evaluate individual suitability before starting treatment.\n\nHow to Use Minoxidil & Finasteride Topical Solution\n\nFor best results:\n\nStep 1\n\nEnsure the scalp is clean and dry.\n\nStep 2\n\nApply the prescribed amount directly to affected scalp areas.\n\nStep 3\n\nSpread evenly if recommended.\n\nStep 4\n\nAllow the solution to dry naturally.\n\nStep 5\n\nWash hands after application.\n\nStep 6\n\nUse consistently according to medical advice.\n\nConsistency is essential for achieving optimal hair regrowth outcomes.\n\nExpected Results Timeline\n\nHair growth requires patience and regular use.\n\nFirst 1–2 Months\n\nSome individuals may notice temporary increased shedding.\n\nThis is often a normal phase as older hairs are replaced by newer growth.\n\n3–4 Months\n\nInitial signs of hair regrowth may become visible.\n\n4–6 Months\n\nHair density and thickness may improve significantly.\n\n6–12 Months\n\nMaximum benefits are often observed with continued treatment.\n\nResults vary based on genetics, age, scalp condition, and severity of hair loss.\n\nSide Effects of Minoxidil & Finasteride Topical Solution\n\nLike all medications, this solution may cause side effects in some users.\n\nCommon Side Effects\nScalp Irritation\n\nMay include:\n\nItching\nRedness\nDryness\nMild burning sensation\nFlaking or Scaling\n\nSome users experience temporary scalp dryness.\n\nIncreased Hair Shedding Initially\n\nA short-term increase in hair fall can occur during the early stages of treatment.\n\nLess Common Side Effects\nHeadache\n\nMild headaches may occur in some individuals.\n\nDizziness\n\nRarely reported with topical use.\n\nUnwanted Hair Growth\n\nHair growth in unintended areas may occur if the solution comes into contact with other skin surfaces.\n\nPotential Finasteride-Related Side Effects\n\nAlthough topical application may reduce systemic exposure, some users may experience:\n\nScalp sensitivity\nLocal irritation\nChanges in libido (rare)\nHormonal-related effects in sensitive individuals\n\nPatients should discuss concerns with their healthcare provider.\n\nSerious Side Effects Requiring Medical Attention\n\nSeek immediate medical assistance if you experience:\n\nSevere allergic reactions\nDifficulty breathing\nSwelling of the face or throat\nChest pain\nRapid heartbeat\nSevere dizziness\n\nThese reactions are uncommon but require prompt evaluation.\n\nPrecautions and Warnings\nFor External Use Only\n\nApply only to the scalp as directed.\n\nAvoid Contact with Eyes\n\nRinse thoroughly with water if accidental contact occurs.\n\nDo Not Apply to Damaged Skin\n\nAvoid use on irritated, infected, or injured scalp areas.\n\nPregnancy and Breastfeeding\n\nWomen who are pregnant, planning pregnancy, or breastfeeding should consult a healthcare professional before use.\n\nKeep Away from Children\n\nStore safely and securely out of reach of children.\n\nStorage Instructions\n\nTo maintain product quality:\n\nStore in a cool, dry place.\nProtect from direct sunlight.\nKeep the container tightly closed.\nAvoid excessive heat and moisture.\nFrequently Asked Questions (FAQs)\nWhat is Minoxidil & Finasteride Topical Solution used for?\n\nIt is used to treat androgenetic alopecia and promote hair regrowth while reducing hair loss.\n\nHow does it differ from Minoxidil alone?\n\nThe addition of Finasteride helps reduce DHT-related follicle shrinkage, providing enhanced hair loss management.\n\nHow long does it take to see results?\n\nVisible improvement typically begins after several months of consistent use.\n\nCan women use this solution?\n\nUse in women should only occur under medical supervision and according to product-specific recommendations.\n\nIs this a permanent cure for baldness?\n\nNo. It helps manage hair loss and support regrowth, but continued use is often necessary to maintain results.\n\nConclusion\n\nMinoxidil & Finasteride Topical Solution is a scientifically advanced hair restoration treatment that combines two of the most effective ingredients available for managing hair loss. By stimulating hair follicles, improving scalp circulation, and reducing DHT-related follicle damage, it offers a comprehensive approach to combating androgenetic alopecia and hair thinning.\n\nRegular use may help reduce hair fall, promote thicker hair growth, improve hair density, and support long-term scalp health. For individuals seeking a non-surgical, clinically supported solution for hair restoration, Minoxidil & Finasteride Topical Solution remains one of the most trusted and effective options available. Always use the product under the guidance of a qualified healthcare professional to achieve safe and optimal results.", "price": 1550.0, "discountamount": 465.0, "currencycode": "INR", "priority": 1000000, "isfreeshipmentavailable": false, "shipmentduration": 1, "_keywords": null, "isarchived": false, "isavailable": true, "applicationid": null, "productindex": 2452, "imageuri": "https://productimages.withfloats.com/actual/6a2946ae286ae8de34d1e922.png", "tileimageuri": "https://productimages.withfloats.com/tile/6a2946ae286ae8de34d1e922.png", "images": null, "totalqueries": 0, "gpid": null, "groupproductid": null, "createdon": "2026-06-10T11:12:45.218Z", "updatedon": "2026-06-10T11:12:45.218Z", "buyonlinelink": null, "producturl": "http://WWW.STERISINDIA.COM/products/minoxidil-finasteride-topical-solution/2452", "availableunits": -1.0, "iscodavailable": false, "isprepaidonlineavailable": false, "maxcodorders": 0, "maxprepaidonlineorders": 0, "uniquepaymenturl": null, "brandname": "MINOXIHAIR F 10%", "category": "DERMATALOGY", "tags": [ "minoxidil & finasteride topical solution", "minoxidil & finasteride topical solution uses", "minoxidil & finasteride topical solution in hindi", "minoxidil &finasteride topical solution", "men's minoxidil & finasteride topical solution", "minoxidil & finasteride topical solution price", "minoxidil & finasteride topical solution hindi", "minoxidil & finasteride topical solution 5", "minoxidil & finasteride topical solution 10", "minoxidil & finasteride topical solution use", "women's minoxidil & finasteride topical solution" ], "variants": false, "keyspecification": null, "otherspecifications": null, "pickupaddressreferenceid": null, "paymenttype": "UniquePaymentUrl", "producttype": "products", "hsncode": null, "gstslab": 0.0, "isnotforsale": false }, { "_id": "6a2937c45f38850c17a50eea", "fptag": "STERISHEALTHCARE", "merchantname": null, "customwidgets": null, "externalsourceid": null, "name": "minoxidil topical solution usp 2%", "description": "Introduction to Minoxidil Topical Solution USP 2%\n\nMinoxidil Topical Solution USP 2% is a clinically proven hair regrowth treatment widely used for managing hair thinning and hair loss in both men and women. Originally developed as a medication for high blood pressure, researchers discovered that Minoxidil had a remarkable ability to stimulate hair growth and improve hair density. Today, it is one of the most trusted and dermatologist-recommended treatments for androgenetic alopecia (pattern baldness) and other forms of hair loss.\n\nHair loss can significantly affect self-confidence and quality of life. Whether caused by genetics, hormonal changes, stress, aging, or medical conditions, thinning hair can be frustrating. Minoxidil Topical Solution USP 2% offers a scientifically backed solution designed to revitalize hair follicles, improve scalp circulation, and promote healthier, thicker hair growth.\n\nThis comprehensive guide explains everything you need to know about Minoxidil Topical Solution USP 2%, including its uses, benefits, mechanism of action, side effects, application methods, and frequently asked questions.\n\nWhat Is Minoxidil Topical Solution USP 2%?\n\nMinoxidil Topical Solution USP 2% is an external-use medication applied directly to the scalp to promote hair regrowth and slow down progressive hair loss. It contains 2% Minoxidil as the active ingredient and is formulated specifically to stimulate hair follicles and encourage healthy hair growth.\n\nThis topical treatment is commonly prescribed or recommended for individuals experiencing:\n\nMale pattern baldness\nFemale pattern hair loss\nHair thinning\nEarly-stage alopecia\nReduced hair density\n\nThe 2% strength is often preferred for women and individuals seeking a milder concentration while still benefiting from effective hair growth stimulation.\n\nComposition of Minoxidil Topical Solution USP 2%\nActive Ingredient\nMinoxidil USP 2% w/v\n\nMinoxidil is a vasodilator that improves blood flow to hair follicles and helps extend the hair growth cycle.\n\nOther Ingredients\n\nDepending on the manufacturer, the formulation may also contain:\n\nPurified Water\nEthanol\nPropylene Glycol\nStabilizing agents\nPreservatives\n\nThese ingredients help ensure proper absorption and effectiveness of the solution.\n\nHow Does Minoxidil Topical Solution USP 2% Work?\n\nMinoxidil works by revitalizing shrinking hair follicles and prolonging the growth phase of the hair cycle.\n\nHair Growth Cycle Overview\n\nHair grows in three main stages:\n\n1. Anagen Phase (Growth Phase)\n\nThe active growth stage where hair follicles produce new hair strands.\n\n2. Catagen Phase (Transition Phase)\n\nA brief period where hair growth slows.\n\n3. Telogen Phase (Resting Phase)\n\nHair eventually sheds and makes way for new growth.\n\nIn people experiencing pattern hair loss, the anagen phase becomes shorter, and hair follicles gradually shrink.\n\nMechanism of Action of Minoxidil\n\nMinoxidil Topical Solution USP 2% works by:\n\nIncreasing Blood Circulation\n\nMinoxidil improves blood flow around hair follicles, ensuring better delivery of oxygen and nutrients.\n\nStimulating Dormant Hair Follicles\n\nIt helps reactivate weakened follicles that have stopped producing healthy hair.\n\nExtending the Growth Phase\n\nMinoxidil prolongs the anagen phase, allowing hair to grow thicker and longer.\n\nEnhancing Follicular Function\n\nHair follicles become healthier and more productive over time.\n\nIncreasing Hair Density\n\nRegular application can improve scalp coverage and hair volume.\n\nUses of Minoxidil Topical Solution USP 2%\n1. Treatment of Androgenetic Alopecia\n\nThe primary use of Minoxidil Topical Solution USP 2% is managing hereditary hair loss in both men and women.\n\nBenefits include:\nReduced hair thinning\nImproved hair density\nEnhanced scalp coverage\nSlowed progression of baldness\n2. Female Pattern Hair Loss\n\nMinoxidil 2% is commonly recommended for women experiencing:\n\nDiffuse hair thinning\nWidening hair part\nReduced hair volume\n\nMany dermatologists consider 2% Minoxidil a first-line treatment option for female hair loss.\n\n3. Early Hair Loss Management\n\nIndividuals noticing initial signs of hair thinning may benefit from early treatment to preserve existing hair.\n\n4. Hair Follicle Revitalization\n\nMinoxidil helps improve the condition of miniaturized follicles, encouraging healthier growth patterns.\n\n5. Hair Density Enhancement\n\nRegular use may result in fuller, thicker-looking hair over time.\n\nKey Benefits of Minoxidil Topical Solution USP 2%\nClinically Proven Hair Regrowth\n\nMinoxidil is one of the most extensively studied and scientifically validated hair growth treatments available today.\n\nNon-Invasive Treatment\n\nUnlike hair transplantation procedures, Minoxidil provides a non-surgical approach to hair restoration.\n\nImproved Hair Thickness\n\nMany users experience:\n\nThicker hair strands\nIncreased hair volume\nBetter scalp coverage\nSlows Progressive Hair Loss\n\nMinoxidil helps slow the natural progression of androgenetic alopecia.\n\nEasy to Apply\n\nThe topical solution can be applied directly to affected scalp areas using a dropper or applicator.\n\nSuitable for Long-Term Use\n\nWith proper medical guidance, Minoxidil can be safely used as part of a long-term hair care regimen.\n\nSupports Hair Follicle Health\n\nImproved blood circulation contributes to healthier follicular activity and stronger hair growth.\n\nBoosts Confidence and Appearance\n\nSuccessful hair regrowth can positively impact:\n\nSelf-esteem\nPersonal appearance\nSocial confidence\nPsychological well-being\nWho Can Use Minoxidil Topical Solution USP 2%?\n\nMinoxidil 2% may be suitable for:\n\nAdult men experiencing early-stage hair loss\nWomen with diffuse hair thinning\nIndividuals with hereditary hair loss\nPatients seeking non-surgical hair restoration options\nPeople looking to improve hair density\n\nA healthcare professional or dermatologist should determine whether this treatment is appropriate for your specific condition.\n\nHow to Apply Minoxidil Topical Solution USP 2%\n\nFor optimal results:\n\nStep 1\n\nEnsure the scalp is clean and completely dry.\n\nStep 2\n\nApply the recommended amount directly to the affected scalp area.\n\nStep 3\n\nGently spread the solution using fingertips if instructed.\n\nStep 4\n\nAllow the solution to dry naturally.\n\nStep 5\n\nWash hands thoroughly after application.\n\nStep 6\n\nUse consistently as directed by your healthcare provider.\n\nRegular application is essential for achieving the best outcomes.\n\nWhen Can Results Be Expected?\n\nHair regrowth is a gradual process.\n\nTypical Timeline\nFirst 1–2 Months\n\nSome users may notice temporary shedding as older hairs are replaced.\n\n3–4 Months\n\nInitial improvements in hair growth may become visible.\n\n4–6 Months\n\nHair density and scalp coverage may continue to improve.\n\n6–12 Months\n\nMaximum benefits are often observed with consistent long-term use.\n\nResults vary from person to person depending on age, genetics, and the severity of hair loss.\n\nWhy Choose Minoxidil Topical Solution USP 2%?\nTrusted Worldwide\n\nMinoxidil remains one of the most recommended hair regrowth treatments globally.\n\nProven Effectiveness\n\nNumerous clinical studies support its ability to promote hair growth and reduce hair loss.\n\nEasy Integration into Daily Routine\n\nApplication requires minimal time and effort.\n\nCost-Effective Hair Loss Solution\n\nCompared to surgical hair restoration procedures, Minoxidil offers an affordable alternative.\n\nSuitable for Men and Women\n\nThe 2% formulation is particularly popular among female users while also benefiting many men with mild to moderate hair loss.\n\nPossible Side Effects of Minoxidil Topical Solution USP 2%\n\nLike any medication, Minoxidil may cause side effects in some individuals.\n\nCommon Side Effects\nScalp Irritation\n\nSome users may experience:\n\nRedness\nItching\nDryness\nMild burning sensation\nFlaking or Scaling\n\nThe scalp may become slightly dry during treatment.\n\nTemporary Hair Shedding\n\nAn increase in hair shedding may occur during the initial weeks of treatment.\n\nThis is often a normal sign that older hairs are being replaced by new growth.\n\nLess Common Side Effects\nHeadache\n\nA small percentage of users may experience mild headaches.\n\nDizziness\n\nRarely, some individuals may feel lightheaded.\n\nUnwanted Hair Growth\n\nHair growth may occur in unintended areas if the solution comes into contact with other parts of the body.\n\nSerious Side Effects Requiring Medical Attention\n\nSeek immediate medical assistance if you experience:\n\nChest pain\nRapid heartbeat\nSevere dizziness\nSwelling of hands or feet\nDifficulty breathing\nSevere allergic reactions\n\nAlthough uncommon, these reactions require prompt evaluation.\n\nPrecautions and Warnings\nFor External Use Only\n\nMinoxidil Topical Solution USP 2% should only be applied to the scalp.\n\nAvoid Contact with Eyes\n\nIf accidental contact occurs, rinse thoroughly with water.\n\nDo Not Apply to Damaged Skin\n\nAvoid use on irritated, infected, or injured scalp areas.\n\nPregnancy and Breastfeeding\n\nConsult a healthcare provider before use during pregnancy or breastfeeding.\n\nKeep Away from Children\n\nStore safely and securely out of reach of children.\n\nStorage Instructions\n\nTo maintain product quality:\n\nStore in a cool, dry place.\nKeep away from direct sunlight.\nClose the container tightly after use.\nProtect from excessive heat and moisture.\nFrequently Asked Questions (FAQs)\nWhat is Minoxidil Topical Solution USP 2% used for?\n\nIt is used to treat hair loss and promote hair regrowth in individuals with androgenetic alopecia and hair thinning.\n\nIs Minoxidil 2% effective for women?\n\nYes. Minoxidil 2% is commonly recommended for female pattern hair loss.\n\nHow long should I use Minoxidil?\n\nHair growth maintenance generally requires continued use as directed by a healthcare professional.\n\nCan Minoxidil cure baldness permanently?\n\nNo. It helps manage hair loss and stimulate regrowth but does not permanently cure hereditary baldness.\n\nCan I use hair products while using Minoxidil?\n\nMost hair care products can be used, but it is advisable to apply them after the solution has completely dried.\n\nConclusion\n\nMinoxidil Topical Solution USP 2% is a trusted, clinically proven, and widely recommended treatment for hair loss and hair thinning. By improving blood circulation to hair follicles, extending the hair growth cycle, and stimulating dormant follicles, it helps promote healthier, thicker, and fuller hair growth over time.", "price": 395.0, "discountamount": 119.0, "currencycode": "INR", "priority": 1000000, "isfreeshipmentavailable": false, "shipmentduration": 1, "_keywords": null, "isarchived": false, "isavailable": true, "applicationid": null, "productindex": 2451, "imageuri": "https://productimages.withfloats.com/actual/6a2937c6210ffc3626055f86.png", "tileimageuri": "https://productimages.withfloats.com/tile/6a2937c6210ffc3626055f86.png", "images": null, "totalqueries": 0, "gpid": null, "groupproductid": null, "createdon": "2026-06-10T10:09:08.796Z", "updatedon": "2026-06-10T10:09:08.796Z", "buyonlinelink": null, "producturl": "http://WWW.STERISINDIA.COM//minoxidil-topical-solution-usp-2-/2451", "availableunits": -1.0, "iscodavailable": false, "isprepaidonlineavailable": false, "maxcodorders": 0, "maxprepaidonlineorders": 0, "uniquepaymenturl": null, "brandname": "MINOXIHAIR 2%", "category": "DERMATALOGY", "tags": [ "minoxidil topical solution usp 2%", "minoxidil topical solution usp 2 %", "minoxidil topical solution usp 2% w/v" ], "variants": false, "keyspecification": null, "otherspecifications": null, "pickupaddressreferenceid": null, "paymenttype": "UniquePaymentUrl", "producttype": "products", "hsncode": null, "gstslab": 0.0, "isnotforsale": false }, { "_id": "694919f0de5d3e57a93413a8", "fptag": "STERISHEALTHCARE", "merchantname": null, "customwidgets": null, "externalsourceid": null, "name": "elagolix 150mg tablet", "description": "Eligolux 150 delivers 150mg of elagolix per tablet, formulated as an oral, once-daily option in convenient packs for ongoing therapy. As a non-peptide GnRH receptor antagonist, it selectively suppresses pituitary gonadotropins, reducing ovarian estrogen production without the flare effect of agonists. Ideal for patients with milder symptoms or those prioritizing bone health, this dose minimizes hypoestrogenic risks while targeting endometriotic pain.\n\nTake Eligolux 150 whole with water, with or without food, preferably at the same time daily. Storage requires a cool, dry environment below 30°C, away from children and moisture. Steris Healthcare ensures GMP-compliant manufacturing, making it accessible across India for endometriosis care.\n\nPrimary Uses and Indications\nEligolux 150 primarily treats moderate endometriosis-associated pain, including dysmenorrhea, chronic pelvic discomfort, and dyspareunia. Endometriosis impacts 10% of reproductive-age women, causing ectopic endometrial growth that triggers inflammation and scarring; elagolix 150mg curbs estrogen-driven progression.\n​\nPrescribed when NSAIDs or combined pills prove inadequate, it excels in non-severe cases, allowing prolonged use. Emerging evidence supports its role in heavy menstrual bleeding from fibroids, though primary approval focuses on pain relief. Start therapy within the first week of menses for optimal synchronization.\n​\nMechanism of Action\nElagolix in Eligolux 150 competitively binds GnRH receptors, dose-dependently inhibiting LH/FSH release. This lowers estradiol by 40-60%—less aggressive than 200mg—halting endometrial tissue proliferation outside the uterus. Peak levels hit in 1 hour, with a 4-6 hour half-life supporting steady-state suppression on QD dosing.\n​\nUnlike agonists, no initial hormone surge occurs, preventing worsened pain. Partial estrogen reduction preserves some bone-protective effects, differentiating it from deeper suppression therapies.\n\nKey Benefits\nEligolux 150 shines in clinical responsiveness: phase 3 trials showed 32% dysmenorrhea resolution versus 20% placebo at 6 months, with 50% pain score drops. Quality-of-life gains include better work attendance, sleep, and relationships, per EQ-5D assessments.\n​\nExtended 24-month approval suits long-term control, with amenorrhea in 40-50% of users reducing bleeding volume by 70%. Oral ease beats injectables, enhancing adherence at 85% in studies. Lower BMD impact (0.5-1% loss/year) allows safer continuation versus higher doses.\n\nBenefit\tTrial Data\tPatient Impact\nPain Reduction\t32-50% dysmenorrhea-free \n​\tDaily activity restoration\nBleeding Control\t70% volume drop \n​\tAnemia prevention\nLong-Term Use:\tUp to 24 months \n​\tSustained relief\nQoL Improvement\tEQ-5D gains \n​\tEmotional well-being\nPotential Side Effects\nVasomotor symptoms dominate: hot flashes (20-30%), headaches (17%), and night sweats (10-15%) emerge early but fade. Nausea (8%), insomnia (7%), and mild depression (5%) affect minorities, with a 70% event rate mostly grade 1.\n​\nBMD decline averages -0.9% at the spine after 12 months, monitored via DEXA. Discontinuation hovers at 5-8%.\n\nSide Effect\tIncidence\tMitigation\nHot Flashes\t20-30% \n​\tVentilation, timing\nHeadache\t17% \n​\tAnalgesics\nBMD Loss\t0.9% \n​\tSupplements, scans\nMood Shifts\t5% \n​\tMonitoring\nSerious Risks and Management\nSuicidality (0.1-0.5%) demands baseline psych screening; halt if worsening. Liver enzymes rise in 1%, requiring LFTs at 3/6 months. Rare anaphylaxis or thromboembolism prompts immediate cessation. Avoid in osteoporosis or smokers >35.\n​\n\nDosage Guidelines\n150 mg once daily for up to 24 months in normal/mild liver function; limit to 6 months in moderate impairment (Child-Pugh B). No titration needed; miss a dose? Resume the next day, no doubling. Pair with 1 g calcium/800 IU vitamin D daily.\n​\n\nPrecautions and Contraindications\nPregnancy category X: mandates non-hormonal birth control during and 1 week post-therapy. Screen hepatic/renal function; avoid severe cases. CYP3A interactions (e.g., rifampin reduces efficacy) need dose review. Breastfeeding is contraindicated.\n​\nClinical Evidence and Efficacy\nElaris trials (n=1,689) confirmed superiority: co-primary endpoints met with 75% responder rates for pain. 12-month extensions showed persistent efficacy and low rebound. Versus 200mg, 150mg balances tolerability for moderate pain.\n​\nConclusion\nEligolux 150 empowers women with moderate endometriosis pain through precise, extended hormonal modulation and proven outcomes. Regular physician oversight maximizes safety and efficacy.\n", "price": 700.0, "discountamount": 210.0, "currencycode": "INR", "priority": 1000000, "isfreeshipmentavailable": false, "shipmentduration": 1, "_keywords": null, "isarchived": false, "isavailable": true, "applicationid": null, "productindex": 2252, "imageuri": "https://productimages.withfloats.com/actual/694a2af01e4092f757d90bb5.png", "tileimageuri": "https://productimages.withfloats.com/tile/694a2af01e4092f757d90bb5.png", "images": null, "totalqueries": 0, "gpid": null, "groupproductid": null, "createdon": "2025-12-22T10:14:08.773Z", "updatedon": "2026-03-26T05:59:45.544Z", "buyonlinelink": null, "producturl": "http://WWW.STERISINDIA.COM//elagolix-150mg-tablet/2252", "availableunits": -1.0, "iscodavailable": false, "isprepaidonlineavailable": false, "maxcodorders": 0, "maxprepaidonlineorders": 0, "uniquepaymenturl": null, "brandname": "ELIGOLUX 150", "category": "GYANECOLOGYRANGE", "tags": [ "elagolix 150mg tablet", "prioritizing bone health.", "endometriotic pain.", "endometrial tissue proliferation outside the uterus.", "Eligolux 150 empowers women with moderate endometriosis pain through precise.", "hormonal modulation and proven outcomes.", "gonadotropins.", "endometriotic pain." ], "variants": false, "keyspecification": null, "otherspecifications": null, "pickupaddressreferenceid": null, "paymenttype": "UniquePaymentUrl", "producttype": "products", "hsncode": null, "gstslab": 0.0, "isnotforsale": false }, { "_id": "6948f4ee5837f90c86a7e578", "fptag": "STERISHEALTHCARE", "merchantname": null, "customwidgets": null, "externalsourceid": null, "name": "Elagolix 200mg ", "description": "Eligolux200 contains 200 mg of elagolix per tablet and is manufactured by Steris Healthcare Pvt Ltd in India as a prescription medication in packs of 3x10 tablets. Elagolix acts as a potent gonadotropin-releasing hormone (GnRH) receptor antagonist, binding competitively to GnRH receptors in the pituitary gland to rapidly reduce estrogen and progesterone levels without the initial flare-\nup seen in agonists. This mechanism starves endometrial-like tissue outside the uterus of hormonal stimulation, shrinking lesions and easing inflammation.\n\nAdminister Eligolux200 orally, swallowed whole with water, with or without food, typically starting within 7 days of menstrual onset. Standard dosing for severe cases involves 200mg twice daily for up to 6 months, or 150mg once daily extended to 24 months, adjusted by physicians based on tolerance and response. Store in a cool, dry place away from moisture and light, keeping out of children's reach.\n\nPrimary Uses\nEligolux200 targets moderate to severe endometriosis-associated pain, including dysmenorrhea (painful periods), nonmenstrual pelvic pain, and dyspareunia (painful intercourse). Endometriosis affects millions globally, causing tissue similar to the uterine lining to grow ectopically, leading to chronic inflammation, adhesions, and scarring. By dosing flexibly, Eligolux200 suits patients needing stronger suppression for intense symptoms, reducing reliance on opioids or surgery.\n\nClinical trials like Elaris EM-I and EM-II showed 75% dysmenorrhea reduction and 50-60% nonmenstrual pain relief at 6-12 months. It also curbs heavy menstrual bleeding in uterine fibroids, offering dual benefits for overlapping conditions. Physicians prescribe it when first-line NSAIDs or oral contraceptives fail, prioritizing non-invasive symptom control.\n​\n\nKey Benefits\nEligolix in Eligolux200 delivers rapid pain relief, with significant improvements in daily pain scales within 3 months versus placebo. Women report 47% better composite pelvic pain scores, enhancing daily activities, work productivity, and intimacy. Quality-of-life metrics improve consistently over 24 weeks, including reduced fatigue and better emotional well-being.\n​\n\nUnlike injectables, its oral form and dose-dependent estrogen suppression allow titration—lower doses minimize hypoestrogenic effects while higher 200mg dosing tackles severe pain. Studies confirm amenorrhea in 25% of users early on, slashing bleeding days by up to 50%. Long-term data up to 12 months with add-back therapy sustains efficacy, preserving bone health better than monotherapy. Patients regain control, avoiding invasive laparoscopies and reclaiming normalcy.\n​\n\nBenefit\tEvidence from Trials'\tImpact on Patients\nDysmenorrhea Reduction:\t75% at 6 months \n​\tFewer missed workdays\nNonmenstrual Pain Relief:\t50-60% improvement \n​\tEnhanced mobility\nBleeding Control:\t14% bleeding days vs. 24% baseline \n​\tImproved hygiene, anemia prevention\nQuality of Life\tSustained over 24 weeks \n​\tBetter sleep, relationships\nPotential Side Effects\nCommon side effects of Eligolux200 mirror hypoestrogenic states: hot flashes, night sweats, headache, and nausea, each affecting about 10% of users. These often lessen as the body adjusts, with 69.5% overall adverse event rate over 24 weeks, mostly mild. Mood changes like irritability or depression occur less commonly, warranting mood monitoring.\n​\n\nBone mineral density (BMD) loss poses a key concern—200mg twice daily causes -1.5% to -2.4% drops at lumbar spine and hip after 6 months, attenuated with calcium/vitamin D or add-back therapy. Rare serious risks include suicidal thoughts, liver enzyme elevations, or allergic reactions like anaphylaxis. Discontinuation due to events stays low at 4-12%. No deaths are linked directly to treatment in trials.\n​\n\nSide Effect Category\tFrequency\tManagement\nVasomotor (Hot Flashes)\t9.9-10% \n​\tLifestyle cooling, dose adjustment\nNeurologic (Headache)\t9.9% \n​\tHydration, analgesics\nBone Loss\tUp to 2.4% at 6 months \n​\tDEXA scans, supplements\nMood Changes\tLess common \n​\tPsychiatric screening\nPrecautions and Contraindications\nAvoid Eligolux200 in pregnancy (risk of early loss), known osteoporosis, severe hepatic impairment, or with strong OATP1B1 inhibitors like cyclosporine or gemfibrozil. Women of childbearing age need effective non-hormonal contraception during and 28 days post-therapy, as it impairs recognition of pregnancy via amenorrhea. Not for pediatrics under 18 or geriatrics lacking data.\n\nScreen for depression history, liver function, and BMD before starting; monitor quarterly. Drug interactions abound with rifampin (reduces levels) or over 50 others like clarithromycin—inform physicians fully. Breastfeeding lacks safety data; weigh risks. Regular blood/urine tests track efficacy and safety.\n​\n\nDosage Guidelines\nInitiate Eligolux200 at 150mg daily for milder cases, escalating to 200mg BID for dyspareunia or severe pain, max 6 months at higher dose. Miss a dose? Take promptly unless near the next; never double. Duration caps at 24 months total, with liver-adjusted lower dosing. Pair with add-back for extended use to curb BMD loss.\n​\n\nPhysicians tailor based on response: 74-77% complete 6-month trials. Swallow intact; no crushing.\n​\n\nClinical Evidence\nPhase III trials (Elaris EM-I/II) randomized 1689 women, proving both doses superior to placebo for co-primary endpoints of dysmenorrhea and nonmenstrual pain. Open-label extensions to 24 weeks maintained gains. A 12-month study with add-back showed persistent relief and <1% additional BMD loss versus placebo. Real-world use echoes this, positioning Eligolix as first oral GnRH antagonist approved for endometriosis.\n​\n\nVersus relugolix, Eligolix offers comparable pelvic pain reduction with adjustable dosing. Indian brands like Eligolux200 align with global standards.\n​\n\nConclusion\nEligolux200 transforms endometriosis management, delivering substantial pain relief and functional gains through precise hormonal control. Balancing robust benefits against manageable risks like BMD monitoring empowers women toward symptom-free lives. Consult healthcare providers for personalized integration into care plans.\n", "price": 1000.0, "discountamount": 300.0, "currencycode": "INR", "priority": 1000000, "isfreeshipmentavailable": false, "shipmentduration": 1, "_keywords": null, "isarchived": false, "isavailable": true, "applicationid": null, "productindex": 2251, "imageuri": "https://productimages.withfloats.com/actual/694a2b9f403179ac7e958ef6.png", "tileimageuri": "https://productimages.withfloats.com/tile/694a2b9f403179ac7e958ef6.png", "images": null, "totalqueries": 0, "gpid": null, "groupproductid": null, "createdon": "2025-12-22T07:36:14.316Z", "updatedon": "2026-03-26T06:00:31.59Z", "buyonlinelink": null, "producturl": "http://WWW.STERISINDIA.COM//elagolix-200mg-/2251", "availableunits": -1.0, "iscodavailable": false, "isprepaidonlineavailable": false, "maxcodorders": 0, "maxprepaidonlineorders": 0, "uniquepaymenturl": null, "brandname": "ELIGOLUX 200", "category": "GYANECOLOGYRANGE", "tags": [ "Elagolix Tablets 200mg", "Elagolix acts as a potent gonadotropin-releasing hormone.", "nonmenstrual pelvic pain.", "adhesions, and scarring", "preserving bone health better than monotherapy.", "avoiding invasive laparoscopies and reclaiming normalcy.", "pituitary gland to rapidly reduce estrogen and progesterone.", "tab elagolix 200mg", "elagolix 200mg.", "elagolix.", "elagolix 200.", "elagolix tablets", "elagolix tablets uses.", "elagolix 200 mg price.", "elagolix mechanism of action.", "elagolix 200 mg uses.", "tab elagolixtab elagolix." ], "variants": false, "keyspecification": null, "otherspecifications": null, "pickupaddressreferenceid": null, "paymenttype": "UniquePaymentUrl", "producttype": "products", "hsncode": null, "gstslab": 0.0, "isnotforsale": false }, { "_id": "66d999cc236afd258ed10348", "fptag": "STERISHEALTHCARE", "merchantname": null, "customwidgets": null, "externalsourceid": null, "name": "Nintedanib 100 mg", "description": "NINTEDONE 100 \nNintedanib 100 mg is a cutting-edge oral medication designed to combat progressive lung conditions and certain cancers, offering hope to patients facing debilitating fibrotic diseases. As a small-molecule tyrosine kinase inhibitor, it targets key pathways involved in abnormal cell growth and tissue scarring, making it a vital therapy for idiopathic pulmonary fibrosis (IPF), systemic sclerosis-associated interstitial lung disease (SSc-ILD), and progressive fibrosing interstitial lung diseases (PF-ILD). Manufactured to high standards, this formulation delivers precise dosing in a convenient capsule form, ensuring consistent absorption and efficacy for long-term management.​\n\nUses of Nintedanib 100 mg\nNintedanib 100 mg stands out for its approved indications in slowing the decline of lung function in adults with IPF, a chronic and fatal lung disease characterized by progressive scarring of lung tissue. It is also indicated for SSc-ILD, where it helps manage lung fibrosis associated with systemic sclerosis, and PF-ILD, covering other chronic fibrosing lung conditions with a progressive phenotype. Beyond pulmonary fibrosis, Nintedanib has shown utility in oncology, particularly when combined with docetaxel for second-line treatment of advanced non-small cell lung cancer (NSCLC) of adenocarcinoma tumor histology, inhibiting tumor angiogenesis and growth.​\n\nThis medication addresses the underlying fibrotic processes by restricting fibroblast proliferation and migration, which are central to lung tissue damage. In clinical practice, physicians prescribe Nintedanib 100 mg for patients with confirmed diagnoses via high-resolution CT scans or lung biopsies, often after other treatments fail. Its versatility extends to off-label considerations in other cancers like pancreatic or colorectal, though primary use remains in respiratory fibrosis and lung cancer, providing a targeted approach where traditional therapies fall short.​\n\nKey Benefits of Nintedanib 100 mg\nOne of the primary benefits of Nintedanib 100 mg is its proven ability to reduce the rate of forced vital capacity (FVC) decline, a key measure of lung function, by up to 50% in IPF patients compared to placebo in landmark trials. This translates to slower disease progression, fewer acute exacerbations, and improved quality of life, allowing patients to maintain daily activities longer. The oral administration enhances patient compliance, avoiding the need for infusions or hospital visits.​\n\nSlows Fibrosis Progression: By inhibiting multiple tyrosine kinases, it curbs excessive scar tissue formation in the lungs, preserving respiratory capacity over time.​\n\nAnti-Angiogenic Effects: In cancer settings, it blocks vascular endothelial growth factor receptors (VEGFR), reducing tumor blood supply and metastasis risk.​\n\nBroad-Spectrum Kinase Inhibition: Targets fibroblast growth factor receptors (FGFR), platelet-derived growth factor receptors (PDGFR), and others, addressing multifaceted disease pathways.​\n\nManageable Long-Term Use: Clinical data supports sustained benefits with dose adjustments, minimizing hospitalizations for respiratory failure.​\n\nImproved Survival Metrics: In combination therapies for NSCLC, it extends progression-free survival, offering valuable time for patients.​\n\nThese advantages make Nintedanib 100 mg a cornerstone in modern pulmonology and oncology, backed by phase III trials demonstrating statistically significant outcomes in diverse patient populations.​\n\nSide Effects of Nintedanib 100 mg\nWhile effective, Nintedanib 100 mg can cause gastrointestinal side effects as the most common issue, affecting over 60% of users primarily due to its impact on kinase signaling in the gut. Diarrhea often starts within the first two weeks and is typically manageable with dose reduction or antidiarrheal agents like loperamide. Other frequent effects include nausea, vomiting, and decreased appetite, which may lead to weight loss if not addressed.​\n\nMore serious side effects warrant close monitoring:\n\nLiver Enzyme Elevations: Hepatotoxicity occurs in about 10-15% of patients, necessitating monthly liver function tests, especially in those with pre-existing liver conditions.​\n\nCardiovascular Risks: Potential for arterial thromboembolism or hypertension; baseline cardiac evaluation is recommended.​\n\nBleeding Events: Due to VEGF inhibition, minor bleeding like epistaxis is common, but gastrointestinal hemorrhage requires immediate attention.​\n\nRare but Severe: Interstitial lung disease progression (paradoxical worsening), perforations, or severe infections in immunocompromised patients.​\n\nPatients should report persistent diarrhea, abdominal pain, jaundice, or unusual fatigue promptly. Contraindications include pregnancy (category D), active bleeding, or hypersensitivity, with strong recommendations against use in moderate to severe hepatic impairment.​\n\nDosage and Administration Insights\nTypically initiated at 150 mg twice daily for IPF and ILD, Nintedanib 100 mg allows for flexible dosing—starting lower at 100 mg BID if tolerated poorly, with food to reduce GI upset. For NSCLC, it's 200 mg BID with docetaxel cycles. Regular monitoring every 2-3 months adjusts for tolerance, emphasizing adherence to slow disease modification.​\n\nConclusion\nNintedanib 100 mg represents a breakthrough in managing progressive fibrotic lung diseases and select cancers, delivering targeted inhibition of fibrotic and angiogenic pathways for tangible clinical benefits. Its ability to slow FVC decline, enhance patient quality of life, and integrate into combination regimens underscores its value, despite manageable side effects like diarrhea that respond well to supportive care. For those battling IPF, SSc-ILD, or NSCLC, Nintedanib 100 mg offers a proactive defense against relentless progression, empowering longer, more active lives under specialist guidance.​", "price": 795.0, "discountamount": 296.0, "currencycode": "INR", "priority": 1000000, "isfreeshipmentavailable": false, "shipmentduration": 7, "_keywords": [ "one capsule", "weight loss", "scar tissue", "key players", "Key Benefits", "lung function", "initial stages", "abdominal pain", "fibrous tissue", "key ingredient", "Bleeding Events", "fibrotic tissue", "daily activities", "tyrosine kinases", "fibrotic process", "Nintedanib 100 mg", "multiple pathways", "active ingredient", "sudden worsenings", "crucial medication", "recommended dosage", "Decreased Appetite", "signaling pathways", "multiple receptors", "overall well-being", "disease progression", "acute exacerbations", "healthcare provider", "Common side effects", "elevated liver enzymes", "Gastrointestinal Issues", "other fibrotic diseases", "Liver Enzyme Elevations", "tyrosine kinase inhibitor", "progressive lung conditions", "other fibrotic lung diseases", "idiopathic pulmonary fibrosis", "potent pharmaceutical formulation", "fibroblast growth factor receptor", "platelet-derived growth factor receptor", "vascular endothelial growth factor receptor" ], "isarchived": false, "isavailable": true, "applicationid": null, "productindex": 1971, "imageuri": "https://productimages.withfloats.com/actual/66d999d4f2036c2969cdeca8.png", "tileimageuri": "https://productimages.withfloats.com/tile/66d999d4f2036c2969cdeca8.png", "images": null, "totalqueries": 0, "gpid": null, "groupproductid": null, "createdon": "2024-09-05T11:45:16.665Z", "updatedon": "2026-03-14T06:46:45.85Z", "buyonlinelink": null, "producturl": "http://WWW.STERISINDIA.COM//nintedanib-100-mg/1971", "availableunits": -1.0, "iscodavailable": false, "isprepaidonlineavailable": false, "maxcodorders": 0, "maxprepaidonlineorders": 0, "uniquepaymenturl": null, "brandname": "NINTEDONE 100 ", "category": "NEPHROLOGYRANGE", "tags": [ "lung conditions and certain cancers", "Nintedanib 100 mg", "pulmonary fibrosis (IPF)", "fibrosis and lung cancer", "nintedanib 100 mg", "nintedanib capsules 100 mg", "nintedanib 100 mg capsules", "nintedanib 100 mg medicine", "nintedanib 100 mg tablet uses", "what is nintedanib 100 mg used for", "how nintedanib 100 mg works", "nintedanib 100 mg uses and benefits", "nintedanib 100 mg for lung disease", "nintedanib 100 mg for pulmonary fibrosis", "nintedanib 100 mg for idiopathic pulmonary fibrosis", "nintedanib 100 mg for interstitial lung disease", "nintedanib capsules for chronic lung disease", "nintedanib 100 mg price in india", "nintedanib 100 mg capsules price", "buy nintedanib 100 mg online", "nintedanib 100 mg supplier india", "nintedanib 100 mg manufacturer", "when should nintedanib 100 mg be taken", "who should take nintedanib 100 mg", "can nintedanib slow lung fibrosis", "how long to take nintedanib 100 mg", "does nintedanib cure pulmonary fibrosis" ], "variants": false, "keyspecification": null, "otherspecifications": null, "pickupaddressreferenceid": "", "paymenttype": "UniquePaymentUrl", "producttype": "products", "hsncode": null, "gstslab": 0.001, "isnotforsale": false }, { "_id": "6662e74687f0960e14a2d95a", "fptag": "STERISHEALTHCARE", "merchantname": null, "customwidgets": null, "externalsourceid": null, "name": "Gefitinib 250mg", "description": "\n\nGEFISTERIS 250 is a premium pharmaceutical formulation containing Gefitinib 250mg, a breakthrough targeted therapy medication manufactured by Steris Healthcare. This innovative oral medication represents a significant advancement in the treatment of non-small cell lung cancer (NSCLC), offering patients a precise, scientifically-designed approach to combating one of the world's most challenging malignancies. GEFISTERIS 250 is specifically engineered to target the underlying molecular mechanisms that drive certain types of lung cancer, providing hope and extended survival for patients who carry specific genetic mutations.\nAs a tyrosine kinase inhibitor, GEFISTERIS 250 works at the cellular level to interrupt the signals that tell cancer cells to grow and divide. This targeted approach differs fundamentally from traditional chemotherapy, which affects both healthy and cancerous cells. By focusing specifically on cancer cells with epidermal growth factor receptor (EGFR) mutations, GEFISTERIS 250 offers a more refined treatment strategy with potentially fewer systemic side effects and improved quality of life during treatment.\nUnderstanding Gefitinib 250mg: The Science Behind GEFISTERIS 250\nGefitinib 250mg, the active pharmaceutical ingredient in GEFISTERIS 250, belongs to a revolutionary class of medications known as epidermal growth factor receptor tyrosine kinase inhibitors (EGFR-TKIs). The development of this medication marked a paradigm shift in oncology, moving from one-size-fits-all chemotherapy approaches to personalized, mutation-specific treatments.\nThe EGFR protein is found on the surface of cells and plays a crucial role in cell growth and division. In normal cells, EGFR activation is carefully regulated. However, in certain lung cancers, mutations in the EGFR gene cause the receptor to remain constantly active, sending continuous signals for the cell to grow, divide, and survive—leading to uncontrolled cancer growth. GEFISTERIS 250 works by blocking the tyrosine kinase activity of the mutated EGFR protein, effectively turning off the growth signal and causing cancer cells to stop proliferating and eventually die.\nThis precision targeting is what makes GEFISTERIS 250 particularly effective for patients whose tumors harbor activating EGFR mutations, particularly the common exon 19 deletions or exon 21 L858R substitution mutations. Before initiating treatment with GEFISTERIS 250, patients undergo molecular testing to confirm the presence of these mutations, ensuring that the therapy is appropriately matched to their specific cancer biology.\nPrimary Uses and Indications of GEFISTERIS 250\nGEFISTERIS 250 is primarily indicated for the treatment of adult patients with metastatic non-small cell lung cancer whose tumors have specific EGFR mutations. The medication is approved for both first-line treatment in newly diagnosed patients and for those whose disease has progressed after platinum-based chemotherapy.\nFirst-Line Treatment: When EGFR mutations are detected in treatment-naïve patients, GEFISTERIS 250 offers an excellent first-line option, often providing superior progression-free survival compared to traditional chemotherapy regimens. Patients starting with targeted therapy typically experience better tolerability and quality of life during initial treatment phases.\nSecond-Line and Beyond: For patients whose cancer has progressed after chemotherapy, GEFISTERIS 250 provides an effective alternative treatment option, particularly when EGFR mutation testing was not performed initially or when the mutation status was unknown at the time of first treatment.\nThe medication is taken orally as a once-daily tablet, offering significant convenience compared to intravenous chemotherapy that requires hospital visits and lengthy infusion times. This oral administration allows patients to maintain greater independence and normalcy in their daily lives while receiving effective cancer treatment.\nKey Benefits of GEFISTERIS 250\n1. Targeted Cancer Fighting Action\nThe primary benefit of GEFISTERIS 250 lies in its precision targeting mechanism. Unlike conventional chemotherapy that attacks all rapidly dividing cells in the body, GEFISTERIS 250 specifically targets cancer cells bearing EGFR mutations. This selective action means that healthy cells are largely spared, resulting in a more favorable side effect profile and better preservation of normal bodily functions during treatment.\n2. Superior Efficacy in EGFR-Mutant NSCLC\nClinical trials have consistently demonstrated that GEFISTERIS 250 and other EGFR-TKIs provide superior progression-free survival compared to chemotherapy in patients with EGFR-mutant NSCLC. Response rates typically range from 60-80% in appropriate patient populations, with many patients experiencing significant tumor shrinkage and symptomatic improvement within weeks of starting treatment.\n3. Improved Quality of Life\nPatients taking GEFISTERIS 250 often report better quality of life compared to those receiving traditional chemotherapy. The medication's targeted nature results in fewer debilitating side effects such as severe nausea, hair loss, and profound fatigue. Many patients can continue working, traveling, and engaging in normal daily activities while on treatment.\n4. Convenient Oral Administration\nGEFISTERIS 250's once-daily oral dosing eliminates the need for frequent hospital visits for intravenous chemotherapy infusions. Patients take one tablet daily at home, providing tremendous convenience and reducing the burden of treatment. This ease of administration contributes significantly to treatment adherence and patient satisfaction.\n5. Rapid Symptom Relief\nMany patients experience rapid improvement in cancer-related symptoms such as cough, shortness of breath, chest pain, and fatigue within the first few weeks of GEFISTERIS 250 treatment. This quick symptomatic relief can dramatically improve quality of life even before significant tumor shrinkage is visible on imaging studies.\n6. Extended Survival Benefits\nLong-term data demonstrates that appropriate use of EGFR-TKIs like GEFISTERIS 250 contributes to extended overall survival in patients with EGFR-mutant lung cancer. When used as part of a comprehensive treatment strategy, including potential sequential therapies after progression, patients can achieve survival times that were unimaginable before the advent of targeted therapies.\n7. Manageable Side Effect Profile\nWhile GEFISTERIS 250 does cause side effects, they are generally more manageable than those associated with traditional chemotherapy. Most side effects can be effectively controlled with supportive medications, dose modifications, or temporary treatment interruptions, allowing patients to continue benefiting from therapy.\n8. Quality Manufacturing by Steris Healthcare\nGEFISTERIS 250 benefits from Steris Healthcare's commitment to pharmaceutical excellence. Each tablet undergoes rigorous quality testing to ensure consistent potency, purity, and bioavailability. This quality assurance means patients receive reliable, effective medication with every dose.\nSide Effects of GEFISTERIS 250 (Gefitinib 250mg)\nWhile GEFISTERIS 250 offers significant therapeutic benefits, patients should be aware of potential side effects. Understanding these effects enables early recognition and appropriate management.\nCommon Side Effects (Affecting 20% or More of Patients):\nSkin Reactions: The most characteristic side effect of GEFISTERIS 250 is an acne-like rash, typically appearing on the face, chest, and back within the first few weeks of treatment. This rash, while cosmetically concerning for some patients, actually correlates with better treatment response. The rash can be managed with topical antibiotics, moisturizers, and sun protection. In severe cases, temporary dose reduction may be necessary.\nDiarrhea: Approximately 50-60% of patients experience diarrhea of varying severity. Mild diarrhea can often be managed with dietary modifications and over-the-counter anti-diarrheal medications like loperamide. Patients should stay well-hydrated and contact their healthcare provider if diarrhea becomes severe or persistent, as dose adjustments may be needed.\nNail Changes: Some patients develop paronychia (nail bed inflammation) or other nail abnormalities. Proper nail care, avoiding trauma to the nail beds, and wearing protective gloves during housework can help minimize these effects.\nDry Skin: Many patients experience skin dryness and itching. Regular use of fragrance-free moisturizers, gentle cleansers, and avoidance of hot showers can help manage these symptoms.\nMouth Sores: Oral mucositis or stomatitis can develop in some patients. Good oral hygiene, avoiding spicy or acidic foods, and using alcohol-free mouthwashes can provide relief.\nLess Common but Serious Side Effects:\nInterstitial Lung Disease (ILD): While rare (1-2% of patients), ILD is the most serious potential side effect of GEFISTERIS 250. Symptoms include sudden onset or worsening of respiratory symptoms such as difficulty breathing, cough, or fever. This requires immediate medical attention and usually necessitates permanent discontinuation of the medication.\nLiver Function Abnormalities: Elevated liver enzymes can occur, requiring regular monitoring through blood tests. Most cases are asymptomatic and reversible with dose modification or temporary discontinuation.\nEye Problems: Dry eyes, corneal erosion, or other ocular issues may develop. Regular use of lubricating eye drops and ophthalmological evaluation when symptoms occur can prevent serious complications.\nGastrointestinal Perforation: Though rare, serious gastrointestinal complications including perforation can occur, particularly in patients with underlying GI conditions.\nManagement Strategies:\nMost side effects can be effectively managed through:\n\nProactive supportive care and prophylactic measures\nDose modifications (reduction to 250mg every other day in some cases)\nTemporary treatment interruptions allowing recovery\nSymptomatic treatment with appropriate medications\nPatient education about early recognition and reporting of symptoms\n\nPatients should maintain open communication with their healthcare team, reporting any new or worsening symptoms promptly. Regular monitoring through clinical visits and laboratory testing helps identify and address side effects before they become serious.\nDosage and Administration Guidelines\nThe standard dose of GEFISTERIS 250 is one 250mg tablet taken orally once daily, with or without food. The tablet should be swallowed whole with water and should not be crushed or chewed. If a dose is missed and it's been less than 12 hours since the scheduled time, patients should take the missed dose. If more than 12 hours have passed, skip the missed dose and resume the regular schedule—never double up on doses.\nTreatment continues until disease progression or unacceptable toxicity occurs. Some patients remain on GEFISTERIS 250 for months or even years if they continue to benefit without prohibitive side effects. Dose modifications may be necessary based on individual tolerance, typically reducing the frequency to every other day rather than lowering the individual dose.\nPrecautions and Important Considerations\nPatients taking GEFISTERIS 250 should be aware of several important precautions. The medication can cause harm to developing fetuses, so women of childbearing potential must use effective contraception during treatment and for at least two weeks after the last dose. Breastfeeding should be avoided during treatment and for two weeks after completion.\nGEFISTERIS 250 can interact with medications that affect stomach acid, including proton pump inhibitors and H2-receptor antagonists. If antacids are needed, they should be taken several hours apart from GEFISTERIS 250. The medication may also interact with certain other drugs metabolized by the liver, so patients should inform their healthcare provider about all medications, supplements, and herbal products they're taking.\nRegular monitoring is essential during GEFISTERIS 250 treatment, including periodic liver function tests, pulmonary symptom assessment, and clinical evaluation for skin and other toxicities. Patients should avoid prolonged sun exposure and use high-SPF sunscreen, as the medication can increase photosensitivity.\nConclusion\nGEFISTERIS 250 represents a transformative treatment option for patients with EGFR-mutant non-small cell lung cancer, offering targeted, effective therapy with a manageable side effect profile. Manufactured by Steris Healthcare with unwavering commitment to quality and patient outcomes, GEFISTERIS 250 delivers Gefitinib 250mg in a formulation designed for optimal bioavailability and consistent therapeutic effect.\nThe medication's precision targeting of cancer-driving mutations, combined with convenient oral administration and generally tolerable side effects, makes GEFISTERIS 250 an excellent choice for eligible patients. While side effects do occur and require monitoring and management, the potential benefits—including tumor response, symptom improvement, extended progression-free survival, and enhanced quality of life—often significantly outweigh the risks for appropriately selected patients.\nSuccess with GEFISTERIS 250 requires partnership between patients and their healthcare teams. Molecular testing to confirm EGFR mutation status before treatment, adherence to the prescribed regimen, proactive management of side effects, and regular monitoring all contribute to optimal outcomes. For many patients with EGFR-mutant lung cancer, GEFISTERIS 250 offers not just treatment, but genuine hope for extended, quality life.\nAs personalized medicine continues to evolve, medications like GEFISTERIS 250 exemplify the power of matching treatments to individual tumor characteristics. Steris Healthcare's commitment to delivering this advanced therapy with assured quality and accessibility ensures that more patients can benefit from the remarkable advances in targeted cancer treatment that Gefitinib 250mg represents.\n", "price": 2760.0, "discountamount": 828.0, "currencycode": "INR", "priority": 1000000, "isfreeshipmentavailable": false, "shipmentduration": 7, "_keywords": [ "food", "Call", "Uses", "Rash", "Note", "NSCLC", "Email", "nausea", "Dosage", "spread", "WhatsApp", "diarrhea", "Gefitinib", "treatment", "One tablet", "GEFISTERIS", "information", "sterispharma", "consultation", "sterisonline", "Side Effects", "cancer cells", "targeted therapy", "Regular monitoring", "healthcare provider", "small cell lung cancer", "healthcare professional", "specific EGFR mutations", "epidermal growth factor receptor", "potential liver function alterations" ], "isarchived": false, "isavailable": true, "applicationid": null, "productindex": 1530, "imageuri": "https://productimages.withfloats.com/actual/667d25ffb56721898510e93e.png", "tileimageuri": "https://productimages.withfloats.com/tile/667d25ffb56721898510e93e.png", "images": null, "totalqueries": 0, "gpid": null, "groupproductid": null, "createdon": "2024-06-07T10:56:06.808Z", "updatedon": "2026-04-15T10:04:00.767Z", "buyonlinelink": null, "producturl": "http://WWW.STERISINDIA.COM//gefitinib-250mg/1530", "availableunits": -1.0, "iscodavailable": false, "isprepaidonlineavailable": false, "maxcodorders": 0, "maxprepaidonlineorders": 0, "uniquepaymenturl": null, "brandname": "GEFISTERIS 250", "category": "Oncology", "tags": [ "gefitinib 250 mg uses", "gefitinib 250 mg online purchase", "gefitinib 250 mg tablets price in india", "non-small cell lung cancer (NSCLC).", "triggered by chemotherapy.", "cancer biology.", "Superior Efficacy in EGFR-Mutant NSCLC", "gefitinib 250mg", "gefitinib 250mg tablet", "gefitinib 250mg tab", "gefitinib 250 mg tablet uses in lung cancer", "gefitinib tablets 250 mg dosage and benefits", "gefitinib 250 mg price in india", "gefitinib 250 mg EGFR inhibitor for NSCLC treatment india" ], "variants": false, "keyspecification": null, "otherspecifications": null, "pickupaddressreferenceid": "", "paymenttype": "UniquePaymentUrl", "producttype": "products", "hsncode": null, "gstslab": 0.001, "isnotforsale": false }, { "_id": "662b90bf49be7218fcf502ed", "fptag": "STERISHEALTHCARE", "merchantname": null, "customwidgets": null, "externalsourceid": null, "name": "minoxidil topical solution usp 10", "description": "MINOXIHAIR 10% \nMinoxidil Topical Solution (10%)\nHair thinning and hair fall are common concerns today, affecting confidence and overall appearance. Factors such as stress, genetics, hormonal imbalance, pollution, and lifestyle changes often contribute to gradual hair loss. MINOXIHAIR 10%, formulated with Minoxidil Topical Solution USP 10%, is a trusted topical solution designed to support hair regrowth and reduce further hair fall when used regularly and correctly.\n\nMINOXIHAIR 10% works directly on the scalp, targeting hair follicles to promote healthier, stronger, and thicker-looking hair. It is widely used by individuals experiencing pattern hair loss and thinning hair on the scalp.\n\nProduct Description\n\nMINOXIHAIR 10% is a high-strength topical formulation containing Minoxidil USP 10%, specially developed for external use on the scalp. The solution is easy to apply, non-greasy, and quickly absorbed, making it suitable for daily hair care routines.\n\nThis topical solution helps improve blood flow to hair follicles, revitalizes inactive follicles, and extends the growth phase of hair. With consistent application, users may notice reduced hair fall and gradual improvement in hair density over time.\n\nUses of Minoxidil Topical Solution USP 10% (MINOXIHAIR 10%)\n\nMINOXIHAIR 10% is primarily used for:\n\nManaging pattern hair loss in men and women\n\nReducing excessive hair fall\n\nStimulating hair regrowth on the scalp\n\nImproving hair thickness and density\n\nRevitalizing weak and miniaturized hair follicles\n\nIt is especially beneficial for individuals who have not achieved desired results with lower-strength formulations and are advised to use a higher concentration.\n\nHow MINOXIHAIR 10% Works\n\nMinoxidil works by increasing blood circulation to the scalp area. Better blood flow means improved delivery of oxygen and nutrients to hair follicles. This helps:\n\nReactivate dormant hair follicles\n\nProlong the anagen (growth) phase of hair\n\nReduce the telogen (shedding) phase\n\nSupport the growth of thicker and stronger hair strands\n\nWith regular use, hair follicles gradually become healthier, leading to visible improvement in hair coverage.\n\nKey Benefits of MINOXIHAIR 10%\n1. Supports Hair Regrowth\n\nMINOXIHAIR 10% encourages new hair growth by stimulating inactive follicles, especially in areas experiencing thinning.\n\n2. Reduces Hair Fall\n\nBy strengthening hair roots, it helps minimize breakage and excessive shedding over time.\n\n3. Improves Hair Density\n\nConsistent application can result in thicker-looking hair and better scalp coverage.\n\n4. High-Strength Formula\n\nThe 10% concentration offers enhanced effectiveness for individuals who need stronger support for hair regrowth.\n\n5. Easy to Use\n\nThe topical solution is simple to apply and fits easily into daily routines.\n\n6. Non-Greasy and Fast Absorbing\n\nDoes not leave heavy residue when used as directed.\n\nHow to Use MINOXIHAIR 10%\n\nApply the solution only on a clean and dry scalp\n\nUse the recommended quantity as advised\n\nGently spread the solution over the affected area\n\nAllow it to dry completely before styling or covering the head\n\nWash hands thoroughly after application\n\nRegular use is essential to achieve visible and lasting results.\n\nSide Effects of Minoxidil Topical Solution USP 10%\n\nLike any topical product, MINOXIHAIR 10% may cause side effects in some users. Most side effects are mild and temporary.\n\nCommon Side Effects\n\nMild scalp irritation\n\nItching or dryness\n\nRedness at the application site\n\nTemporary hair shedding during initial weeks\n\nThis initial shedding is usually a sign that the product is working, as old hairs make way for new growth.\n\nLess Common Side Effects\n\nBurning sensation on the scalp\n\nFlaking or scaling\n\nUnwanted hair growth on nearby areas if the solution spreads\n\nIf severe irritation or discomfort occurs, use should be stopped and professional advice sought.\n\nPrecautions While Using MINOXIHAIR 10%\n\nFor external use only\n\nAvoid contact with eyes, mouth, or broken skin\n\nDo not apply more than the recommended amount\n\nNot suitable for sudden or unexplained hair loss\n\nAvoid use if the scalp is infected or inflamed\n\nConsistency is important; stopping use may reverse benefits\n\nResults vary from person to person depending on genetics, scalp condition, and regularity of use.\n\nWho Can Use MINOXIHAIR 10%\n\nAdults experiencing pattern hair loss\n\nIndividuals with thinning hair on the scalp\n\nThose advised to use a higher-strength minoxidil formulation\n\nIt is not recommended for children or for hair loss caused by medical conditions unless advised.\n\nExpected Results\n\nInitial shedding may occur within the first few weeks\n\nVisible improvement usually starts after 3–4 months\n\nBest results are seen with continuous long-term use\n\n", "price": 786.0, "discountamount": 386.3, "currencycode": "INR", "priority": 1000000, "isfreeshipmentavailable": false, "shipmentduration": 7, "_keywords": [ "body", "time", "doctor", "redness", "hair loss", "medication", "blood flow", "MINOXIHAIR", "individuals", "other parts", "best results", "Side effects", "external use", "10% minoxidil", "hair regrowth", "hair follicles", "severe reactions", "scalp irritation", "healthcare provider", "thicker, fuller hair", "male pattern baldness", "Minoxidil Topical Solution" ], "isarchived": false, "isavailable": true, "applicationid": null, "productindex": 760, "imageuri": "https://productimages.withfloats.com/actual/662b90c3c20e06ddeb998bfa.png", "tileimageuri": "https://productimages.withfloats.com/tile/662b90c3c20e06ddeb998bfa.png", "images": null, "totalqueries": 0, "gpid": null, "groupproductid": null, "createdon": "2024-04-26T11:32:15.135Z", "updatedon": "2026-03-12T06:58:51.214Z", "buyonlinelink": null, "producturl": "http://WWW.STERISINDIA.COM//minoxidil-topical-solution-usp-10/760", "availableunits": -1.0, "iscodavailable": false, "isprepaidonlineavailable": false, "maxcodorders": 0, "maxprepaidonlineorders": 0, "uniquepaymenturl": null, "brandname": "MINOXIHAIR 10%", "category": "DERMATALOGY", "tags": [ "minoxidil topical solution usp 10 uses", "minoxidil topical solution usp 10 for hair regrowth", "minoxidil 10 percent topical solution usp", "minoxidil topical solution usp 10 uses", "minoxidil topical solution usp 10 benefits", "minoxidil topical solution usp 10 price in India", "minoxidil topical solution usp 10 for women", "minoxidil topical solution usp 10 how to use", "how does minoxidil topical solution usp 10 work", "is minoxidil topical solution usp 10 effective", "minoxidil topical solution usp 10 side effects", "how long to use minoxidil topical solution usp 10", "minoxidil topical solution usp 10 hair fall treatment", "buy minoxidil topical solution usp 10 online", "best minoxidil topical solution usp 10 in India", "minoxidil topical solution usp 10 for hair loss", "minoxidil topical solution usp 10 manufacturer", "minoxidil topical solution usp 10 supplier India" ], "variants": false, "keyspecification": null, "otherspecifications": null, "pickupaddressreferenceid": "", "paymenttype": "UniquePaymentUrl", "producttype": "products", "hsncode": null, "gstslab": 0.001, "isnotforsale": false }, { "_id": "662b8fdce6d2b71ee071e862", "fptag": "STERISHEALTHCARE", "merchantname": null, "customwidgets": null, "externalsourceid": null, "name": "minoxidil 5%", "description": "Hair loss is a widespread concern affecting millions of men and women globally. It can occur due to genetics, hormonal imbalance, stress, nutritional deficiencies, aging, environmental pollution, and lifestyle factors. One of the most trusted and clinically proven solutions for managing hair loss is Minoxidil 5%.\n\nMinoxidil 5% is a topical hair regrowth treatment widely recommended by dermatologists for individuals experiencing androgenetic alopecia (male pattern baldness), thinning hair, and receding hairline. It is designed to stimulate hair follicles, improve scalp circulation, and support natural hair regrowth over time.\n\nWith consistent use, Minoxidil 5% helps increase hair density, reduce hair fall, and promote thicker, healthier hair growth. It is considered one of the most effective non-surgical treatments for hair restoration worldwide.\n\nWhat is Minoxidil 5%?\n\nMinoxidil 5% is a topical solution or foam formulation used to treat hair loss and promote hair regrowth. It works directly on the scalp by activating inactive or weakened hair follicles, encouraging them to re-enter the growth phase.\n\nOriginally developed as an oral medication for high blood pressure, Minoxidil was later discovered to have a side effect of increased hair growth. This led to its development as a topical treatment for alopecia.\n\nToday, Minoxidil 5% is widely used in dermatology for:\n\nMale pattern baldness\nHair thinning\nReceding hairline\nPatchy hair loss\nOverall hair density improvement\nHow Does Minoxidil 5% Work?\n\nMinoxidil 5% works through multiple biological mechanisms that support hair regrowth and scalp health.\n\n1. Improves Blood Circulation in Scalp\n\nMinoxidil acts as a vasodilator, increasing blood flow to the hair follicles. Improved circulation delivers essential oxygen and nutrients that support hair growth.\n\n2. Stimulates Hair Follicles\n\nDormant or inactive hair follicles are reactivated, allowing new hair strands to grow.\n\n3. Extends Growth Phase (Anagen Phase)\n\nHair growth occurs in cycles. Minoxidil extends the anagen (growth) phase, resulting in longer and thicker hair strands.\n\n4. Strengthens Hair Follicle Activity\n\nIt enhances follicular cell activity, improving overall hair production and scalp health.\n\nMechanism of Action of Minoxidil 5%\n\nThe exact mechanism is not fully understood, but scientific research suggests several key actions:\n\nActivation of potassium channels in follicles\nIncreased vascular endothelial growth factor (VEGF) production\nImproved oxygen and nutrient delivery to scalp\nProlongation of anagen phase\nStimulation of dermal papilla cells\n\nThese combined effects result in improved hair regrowth and reduced hair shedding.\n\nUses of Minoxidil 5%\n\nMinoxidil 5% is commonly used for various hair-related conditions:\n\n1. Male Pattern Baldness\n\nIt is widely used to treat androgenetic alopecia in men, helping slow down hair loss and stimulate regrowth.\n\n2. Hair Thinning\n\nHelps improve overall hair thickness and density.\n\n3. Receding Hairline\n\nSupports regrowth in early-stage hairline recession.\n\n4. Crown Hair Loss\n\nEffective in improving hair coverage on the crown area of the scalp.\n\n5. General Hair Regrowth Support\n\nUsed as part of long-term hair care therapy.\n\nKey Benefits of Minoxidil 5%\n1. Clinically Proven Hair Regrowth\n\nMinoxidil 5% is one of the most researched topical treatments for hair regrowth, with proven effectiveness in multiple clinical studies.\n\n2. Reduces Hair Fall\n\nRegular use helps reduce excessive hair shedding over time.\n\n3. Improves Hair Density\n\nIt increases hair thickness, giving fuller and healthier-looking hair.\n\n4. Revives Dormant Hair Follicles\n\nHelps stimulate inactive follicles and encourages new hair growth.\n\n5. Easy Topical Application\n\nSimple to apply directly on the scalp, making it convenient for daily use.\n\n6. Non-Surgical Treatment\n\nOffers a safe alternative to hair transplant procedures.\n\n7. Suitable for Long-Term Use\n\nCan be used continuously under medical supervision for sustained results.\n\n8. Boosts Confidence\n\nImproved hair appearance can enhance self-esteem and confidence.\n\nINDICATIONS OF MINOXIDIL 5%\n\nMinoxidil 5% is indicated for:\n\nAndrogenetic alopecia (male pattern baldness)\nEarly-stage hair loss\nHair thinning\nReceding hairline\nCrown baldness\nGeneral hair density improvement\nExpected Results Timeline\n\nHair regrowth with Minoxidil 5% is gradual and requires consistency.\n\n1–2 Months\nPossible temporary shedding (normal phase transition)\n3–4 Months\nReduction in hair fall\nEarly signs of regrowth\n6 Months\nVisible improvement in hair density\n9–12 Months\nNoticeable thickening and scalp coverage improvement\nHow to Use Minoxidil 5%\nStep 1: Clean Scalp\n\nEnsure the scalp is clean and dry before application.\n\nStep 2: Apply Solution\n\nApply the recommended amount directly to affected areas.\n\nStep 3: Spread Gently\n\nMassage lightly to ensure even distribution.\n\nStep 4: Let It Dry\n\nAllow the solution to dry naturally.\n\nStep 5: Wash Hands\n\nWash hands thoroughly after application.\n\n👉 Use exactly as prescribed by a healthcare professional.\n\nSide Effects of Minoxidil 5%\n\nMinoxidil 5% is generally well tolerated, but some users may experience side effects.\n\nCommon Side Effects\nScalp irritation\nDryness\nItching\nRedness\nFlaking\nTemporary Shedding\n\nSome users may notice increased hair shedding initially. This is usually temporary and part of the natural hair cycle adjustment.\n\nSerious Side Effects of Minoxidil 5%\n\nAlthough rare, serious side effects may include:\n\nChest pain\nRapid heartbeat\nDizziness\nSwelling in hands or feet\nSevere allergic reactions\nDifficulty breathing\n\nIf any of these occur, medical attention should be sought immediately.\n\nPrecautions & Warnings\nAvoid use on broken or infected scalp\nNot recommended without medical advice during pregnancy or breastfeeding\nDo not apply near eyes or mouth\nUse consistently for best results\nDiscontinuation may lead to gradual hair loss reversal\nWho Should Use Minoxidil 5%?\n\nMinoxidil 5% is suitable for:\n\nMen experiencing pattern baldness\nIndividuals with thinning hair\nEarly-stage hair loss patients\nPeople seeking non-surgical hair restoration\nAdults with scalp hair weakening\nWhy Choose Minoxidil 5%?\n\nMinoxidil 5% is one of the most trusted dermatological solutions because:\n\nIt is clinically tested\nIt is widely recommended by doctors\nIt supports natural hair regrowth\nIt is easy to use\nIt offers visible results with consistency\nGEO SEO Benefits (India Market Focus)\n\nIn India, Minoxidil 5% is widely used due to increasing cases of hair fall caused by:\n\nPollution\nStress\nNutritional deficiencies\nLifestyle imbalance\n\nIt is available through pharmacies, dermatology clinics, and online platforms, making it easily accessible across urban and rural regions.\n\nFrequently Asked Questions (FAQs)\nWhat is Minoxidil 5% used for?\n\nIt is used for hair regrowth and treatment of hair loss conditions.\n\nHow long does Minoxidil take to show results?\n\nUsually 3 to 6 months with consistent use.\n\nCan Minoxidil regrow lost hair?\n\nIt can stimulate regrowth in active or dormant follicles but not completely dead follicles.\n\nIs Minoxidil safe for long-term use?\n\nYes, under medical supervision.\n\nDoes hair fall increase initially?\n\nYes, temporary shedding may occur in early weeks.\n\nConclusion\n\nMinoxidil 5% is a scientifically proven and globally trusted hair regrowth treatment designed to combat hair loss, stimulate follicles, and improve hair density. It works by increasing scalp blood circulation, extending the hair growth phase, and activating dormant follicles.\n\nFor individuals struggling with thinning hair, receding hairlines, or pattern baldness, Minoxidil 5% offers a reliable, non-surgical, and effective solution. With consistent use, proper application, and patience, it can significantly improve hair health and restore confidence.", "price": 655.0, "discountamount": 355.0, "currencycode": "INR", "priority": 1000000, "isfreeshipmentavailable": false, "shipmentduration": 7, "_keywords": [ "time", "areas", "dosage", "guidance", "thinning", "symptoms", "concerning", "blood flow", "MINOXIHAIR", "individuals", "Regular use", "blood vessels", "hair follicles", "optimal results", "topical solution", "scalp irritation", "mild side effects", "active ingredient", "facial hair growth", "Minoxidil Solution", "HAIR GAIN TREATMENT", "healthcare provider", "thicker, fuller hair", "male pattern baldness", "healthcare professional", "application instructions" ], "isarchived": false, "isavailable": true, "applicationid": null, "productindex": 759, "imageuri": "https://productimages.withfloats.com/actual/662b8fdfc20e06ddeb99862e.png", "tileimageuri": "https://productimages.withfloats.com/tile/662b8fdfc20e06ddeb99862e.png", "images": null, "totalqueries": 0, "gpid": null, "groupproductid": null, "createdon": "2024-04-26T11:28:28.926Z", "updatedon": "2026-06-09T11:04:02.618Z", "buyonlinelink": null, "producturl": "http://WWW.STERISINDIA.COM//minoxidil-5-/759", "availableunits": -1.0, "iscodavailable": false, "isprepaidonlineavailable": false, "maxcodorders": 0, "maxprepaidonlineorders": 0, "uniquepaymenturl": null, "brandname": "MINOXIHAIR 5%", "category": "DERMATALOGY", "tags": [ "minoxidil 5% for hair regrowth", "minoxidil 5% solution uses", "minoxidil 5% foam benefits", "minoxidil 5% for men hair loss", "minoxidil 5% for women hair thinning", "how to use minoxidil 5% correctly", "minoxidil 5% dosage for hair fall", "minoxidil 5% topical solution guide", "minoxidil 5% hair growth timeline", "minoxidil 5% for frontal baldness", "minoxidil 5% for crown hair loss", "minoxidil 5% vs 2% difference", "minoxidil 5% foam vs liquid", "minoxidil 5% price in india", "minoxidil 5% online buy", "minoxidil 5% for alopecia", "minoxidil 5% solution", "minoxidil 5% for hair regrowth", "minoxidil 5 hair growth treatment", "minoxidil 5% hair fall treatment", "minoxidil topical hair growth solution", "minoxidil 5% for thinning hair", "how to use minoxidil 5% for hair growth", "what is minoxidil 5% used for", "can women use minoxidil 5%", "minoxidil 5% price in india", "minoxidil 5% solution buy online", "minoxidil 5% hair growth solution price", "Minoxidil 5% Hair Growth Solution" ], "variants": false, "keyspecification": null, "otherspecifications": null, "pickupaddressreferenceid": "", "paymenttype": "UniquePaymentUrl", "producttype": "products", "hsncode": null, "gstslab": 0.001, "isnotforsale": false }, { "_id": "6a952bdada41ea9aeeec5e4a", "fptag": "STERISHEALTHCARE", "merchantname": null, "customwidgets": null, "externalsourceid": null, "name": "Semaglutide injection 8 mg", "description": "The semaglutide injection, 8 mg, contains a total of 8 mg of semaglutide, a long-acting GLP-1 receptor agonist. It is used under medical supervision as part of treatment for appropriate adults with type 2 diabetes mellitus and, depending on the specific approved product and indication, for cardiovascular risk reduction and chronic weight management.\n1. Product Overview & Specifications\nAn 8 mg/3 mL semaglutide pen contains 8 mg of the active medicine in a 3 mL delivery system. When specifically designed to provide 2 mg per weekly dose, the total quantity can provide four 2 mg doses.\nActive Ingredient: Semaglutide\nTotal Strength: 8 mg\nExample Presentation: 8 mg/3 mL multi-dose pen\nDrug Class: GLP-1 receptor agonist\nRoute: Subcutaneous injection\nCommon Injection Areas: Abdomen, thigh, or upper arm\nAdministration: Once weekly, according to the prescribed schedule\nMechanism of Action\nSemaglutide mimics the activity of the naturally occurring hormone GLP-1 (glucagon-like peptide-1). It acts on GLP-1 receptors involved in blood-glucose regulation, digestion, and appetite.\nImproves glucose-dependent insulin release: Semaglutide encourages the pancreas to release insulin when blood glucose levels are elevated.\nReduces glucagon secretion: It lowers inappropriate glucagon release, helping reduce the amount of glucose produced by the liver.\nSlows gastric emptying: Semaglutide can delay the movement of food from the stomach, contributing to prolonged fullness.\nReduces appetite: Its effects on appetite-regulating pathways in the brain can decrease hunger and food intake.\n2. Primary Indications & Uses\nSemaglutide may be prescribed for several clinically established purposes depending on the specific formulation, approved labeling, and patient's medical condition.\nType 2 Diabetes Management\nSemaglutide can be used alongside appropriate diet and physical activity to improve blood-glucose control in adults with type 2 diabetes.\nCardiovascular Risk Reduction\nIn eligible adults with type 2 diabetes and established cardiovascular disease, certain semaglutide products have demonstrated a reduction in the risk of major cardiovascular events, including cardiovascular death, non-fatal heart attack, and non-fatal stroke.\nKidney Disease\nCertain semaglutide formulations and indications have demonstrated kidney-related benefits in specific populations. The appropriate product and indication should be determined by a healthcare professional.\nChronic Weight Management\nSemaglutide is also used for long-term weight management in eligible adults with obesity or overweight accompanied by weight-related health conditions, depending on the approved formulation and local prescribing guidance.\n3. Key Benefits of Semaglutide 8 mg Therapy\nClinical Area\nPotential Therapeutic Role\nBlood-Glucose Control\nHelps lower elevated blood glucose and improve glycemic control in appropriate patients.\nWeight Management\nReduces appetite and food intake, supporting sustained weight reduction when prescribed for this purpose.\nCardiovascular Health\nCertain approved semaglutide indications can reduce major cardiovascular event risk in eligible patients.\nMetabolic Support\nInfluences glucose regulation, appetite, insulin secretion, and glucagon activity.\nWeekly Administration\nA once-weekly injection can provide a convenient treatment schedule when prescribed.\n\n4. Side Effects & Safety Warnings\nCommon Adverse Reactions\nDigestive symptoms are among the most frequently reported adverse effects, particularly when treatment is initiated or the dose is increased.\nPossible side effects include:\nNausea\nVomiting\nDiarrhea\nConstipation\nAbdominal discomfort\nBloating\nBelching\nIndigestion or heartburn\nReduced appetite\nThese effects may improve as the body becomes accustomed to treatment.\nFrequently Asked Questions\n1. How much weight can you lose with semaglutide?\nWeight reduction varies significantly between individuals and depends on the prescribed formulation, dose, treatment duration, diet, physical activity, and adherence. Clinical trials of approved weight-management regimens have demonstrated substantial average percentage weight loss over extended treatment periods.\n2. How much is 8 units of semaglutide in mL?\nOn a U-100 insulin syringe, 100 units corresponds to 1 mL, so 8 units corresponds to 0.08 mL. However, this conversion only describes syringe volume. It does not determine the amount of semaglutide in mg because the medication concentration varies between products. Always verify the exact concentration before measuring any dose.\n3. Is semaglutide injection safe for weight loss?\nSemaglutide can be an effective treatment for weight management when an approved formulation is prescribed to an eligible patient and used under appropriate medical supervision. It has important contraindications and warnings, including risks involving the gastrointestinal system, gallbladder, pancreas, kidneys, and thyroid C-cell tumors.\n4. How many mg of semaglutide are used for weight loss?\nThe appropriate dose depends on the specific semaglutide product. Weight-management treatment commonly begins with a lower dose and is gradually increased to a maintenance dose to improve tolerability. The maintenance dose should be determined according to the product's approved prescribing information and the healthcare professional's instructions.\n5. How much weight can I lose in 2 months with semaglutide?\nThere is no guaranteed amount of weight loss during the first two months. Individual results vary because treatment generally begins at a lower dose and is increased gradually. Diet, physical activity, starting weight, medical conditions, and adherence also affect the result.\n6. What happens when you stop semaglutide?\nAfter discontinuation, semaglutide gradually leaves the body. Appetite and food intake may increase as its effects decrease, and some people regain weight. Maintaining healthy eating and physical activity habits may help support weight management after treatment, but discontinuation should be discussed with a healthcare professional.\n7. How long does an 8 mg/3 mL semaglutide pen last?\nIf a specific 8 mg/3 mL pen is designed to deliver 2 mg per weekly dose, it contains four 2 mg doses and therefore provides approximately four weeks of treatment. The actual duration depends on the specific device and prescribed dosing instructions.\n8. What is semaglutide injection 8 mg used for?\nSemaglutide is used for approved indications such as improving blood-glucose control in type 2 diabetes and, depending on the formulation, supporting chronic weight management and reducing cardiovascular risk in eligible patients.\n9. What foods should be avoided while taking semaglutide?\nLarge, high-fat, greasy, or fried meals may worsen gastrointestinal symptoms such as nausea, bloating, and reflux. Smaller meals and balanced food choices may be easier to tolerate. Alcohol intake should also be discussed with a healthcare professional.\n10. Can you eat bananas while taking semaglutide?\nYes, bananas can generally be included in a balanced diet while using semaglutide. Portion size should be considered as part of an individual's overall calorie and carbohydrate intake, particularly for people managing diabetes.\n11. What is the best time of day to inject semaglutide?\nSemaglutide injections can generally be administered at any time of day, with or without meals, depending on the specific product instructions. The injection should be taken on the same day each week as prescribed.\n12. Will I lose weight during the first week of semaglutide?\nSome people may notice an early change in appetite or body weight, while others may not see a significant difference initially. Early treatment doses are generally introduced gradually to help the body adjust rather than to produce immediate maximum weight loss.\n13. How quickly does semaglutide start lowering blood sugar?\nSemaglutide begins acting after administration, but the degree and timing of blood-glucose improvement vary. Significant treatment effects develop progressively, particularly as the prescribed dose is gradually adjusted.\n14. What should I do if I miss a semaglutide dose?\nThe correct missed-dose procedure depends on the specific semaglutide product. Follow the instructions supplied with your prescribed product. Do not take an extra dose to compensate for a missed injection.\n15. Where is the best place to inject semaglutide?\nSemaglutide is administered subcutaneously. Common injection sites include the abdomen, front of the thigh, or upper arm, according to the product instructions. Rotating injection locations can help reduce repeated irritation at one site.\nConclusion\nSemaglutide injection 8 mg contains semaglutide, a long-acting GLP-1 receptor agonist that influences blood-glucose regulation, glucagon secretion, gastric emptying, and appetite. Depending on the specific formulation and approved indication, semaglutide may be used for type 2 diabetes management, chronic weight management, and cardiovascular risk reduction in eligible patients.\nAn 8 mg/3 mL presentation designed for 2 mg weekly dosing can provide four weekly doses. However, semaglutide concentrations, pen designs, approved doses, and indications can differ between products. Treatment should therefore follow the exact product instructions and a healthcare professional's prescription.", "price": 7800.0, "discountamount": 2340.0, "currencycode": "INR", "priority": 1000000, "isfreeshipmentavailable": false, "shipmentduration": 1, "_keywords": null, "isarchived": false, "isavailable": true, "applicationid": null, "productindex": 2498, "imageuri": "https://productimages.withfloats.com/actual/6a952bdd8359c1b7edbc7468.png", "tileimageuri": "https://productimages.withfloats.com/tile/6a952bdd8359c1b7edbc7468.png", "images": null, "totalqueries": 0, "gpid": null, "groupproductid": null, "createdon": "2026-08-31T07:23:06.814Z", "updatedon": "2026-08-31T07:23:06.814Z", "buyonlinelink": null, "producturl": "http://WWW.STERISINDIA.COM//semaglutide-injection-8-mg/2498", "availableunits": -1.0, "iscodavailable": false, "isprepaidonlineavailable": false, "maxcodorders": 0, "maxprepaidonlineorders": 0, "uniquepaymenturl": null, "brandname": "SAMIGLUTIDE 8MG", "category": "DIABETIC RANGE", "tags": [ "Semaglutide injection 8 mg", "semaglutide injection 8 mg", "semaglutide 8 mg injection uses", "semaglutide 8 mg injection benefits", "semaglutide 8 mg injection dosage" ], "variants": false, "keyspecification": null, "otherspecifications": null, "pickupaddressreferenceid": null, "paymenttype": "UniquePaymentUrl", "producttype": "products", "hsncode": null, "gstslab": 0.0, "isnotforsale": false } ], "hasmoreitems": false, "isapirequest": false, "totalresults": 27, "query": null, "floatingpoint": null }